Bevacizumab, when added to chemotherapy regimen for Aged patients with lung cancer, does not increase survival rates
Item
Title
Bevacizumab, when added to chemotherapy regimen for Aged patients with lung cancer, does not increase survival rates
Description
Research Activities (2013), Agency for Healthcare Research and Quality (AHRQ).
Alternative Title
Research Activities
Date
Date Created
8/14/2014
Language
English
Publisher
US Dept of Health and Human Services
Source
Subject
Type
Journal Article
issn
1537-0224
issue
390
page end
13
page start
12
volume
Feb